Latest Insider Transactions at Health Catalyst, Inc. (HCAT)
This section provides a real-time view of insider transactions for Health Catalyst, Inc. (HCAT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Health Catalyst, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Health Catalyst, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2025
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
27,425
-21.52%
|
$54,850
$2.64 P/Share
|
|
Dec 04
2025
|
Julie Larson Green |
SELL
Open market or private sale
|
Direct |
47,997
-39.48%
|
$95,994
$2.67 P/Share
|
|
Dec 01
2025
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
14,387
-10.15%
|
$28,774
$2.9 P/Share
|
|
Dec 01
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
6,209
+4.75%
|
-
|
|
Dec 01
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
5,731
+4.5%
|
-
|
|
Dec 01
2025
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55,715
-3.85%
|
$111,430
$2.9 P/Share
|
|
Dec 01
2025
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,619
-7.72%
|
$41,238
$2.9 P/Share
|
|
Dec 01
2025
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,401
-4.37%
|
$32,802
$2.9 P/Share
|
|
Dec 01
2025
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,762
-6.38%
|
$19,524
$2.9 P/Share
|
|
Sep 24
2025
|
Benjamin Albert President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
467,000
+44.69%
|
-
|
|
Sep 05
2025
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
6,175
-4.17%
|
$18,525
$3.35 P/Share
|
|
Sep 02
2025
|
David Coy Ross Chief Tech & Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,360
-1.62%
|
$10,080
$3.36 P/Share
|
|
Sep 02
2025
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,138
-2.08%
|
$9,414
$3.36 P/Share
|
|
Sep 02
2025
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,854
-1.83%
|
$8,562
$3.36 P/Share
|
|
Sep 02
2025
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,335
-0.57%
|
$25,005
$3.36 P/Share
|
|
Sep 02
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,663
-1.81%
|
$10,989
$3.36 P/Share
|
|
Sep 02
2025
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,613
-0.97%
|
$7,839
$3.36 P/Share
|
|
Sep 02
2025
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,578
-1.21%
|
$13,734
$3.36 P/Share
|
|
Sep 01
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
4,970
+4.03%
|
-
|
|
Sep 01
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
4,588
+3.81%
|
-
|
|
Sep 01
2025
|
Justin Spencer |
BUY
Grant, award, or other acquisition
|
Direct |
68,572
+50.0%
|
-
|
|
Jul 09
2025
|
S. Dawn Smith |
BUY
Grant, award, or other acquisition
|
Direct |
36,231
+26.27%
|
-
|
|
Jul 09
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
36,231
+24.57%
|
-
|
|
Jul 09
2025
|
John A Kane |
BUY
Grant, award, or other acquisition
|
Direct |
36,231
+17.51%
|
-
|
|
Jul 09
2025
|
Green Jill Hoggard |
BUY
Grant, award, or other acquisition
|
Direct |
36,231
+36.17%
|
-
|
|
Jul 09
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
36,231
+24.23%
|
-
|
|
Jun 05
2025
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
6,057
-3.85%
|
$18,171
$3.94 P/Share
|
|
Jun 02
2025
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,965
-1.87%
|
$8,895
$3.63 P/Share
|
|
Jun 02
2025
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,658
-0.59%
|
$25,974
$3.63 P/Share
|
|
Jun 02
2025
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,712
-1.0%
|
$8,136
$3.63 P/Share
|
|
Jun 02
2025
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,747
-1.23%
|
$14,241
$3.63 P/Share
|
|
Jun 02
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,802
-1.85%
|
$11,406
$3.63 P/Share
|
|
Jun 02
2025
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,255
-2.03%
|
$9,765
$3.63 P/Share
|
|
Jun 01
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
4,080
+5.03%
|
-
|
|
Jun 01
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
3,766
+4.78%
|
-
|
|
May 05
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-2.47%
|
$20,836
$4.1 P/Share
|
|
Apr 03
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-2.41%
|
$20,836
$4.15 P/Share
|
|
Mar 06
2025
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
13,827
-7.93%
|
$55,308
$4.55 P/Share
|
|
Mar 05
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,902
-7.25%
|
$67,608
$4.52 P/Share
|
|
Mar 03
2025
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,677
-2.25%
|
$134,708
$4.58 P/Share
|
|
Mar 03
2025
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-4.52%
|
$30,100
$4.58 P/Share
|
|
Mar 03
2025
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,800
-2.73%
|
$43,200
$4.58 P/Share
|
|
Mar 03
2025
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,304
-2.61%
|
$29,216
$4.58 P/Share
|
|
Mar 03
2025
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,024
-4.92%
|
$36,096
$4.58 P/Share
|
|
Mar 03
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,232
-3.81%
|
$36,928
$4.58 P/Share
|
|
Mar 01
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
3,033
+3.99%
|
-
|
|
Mar 01
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
2,450
+3.32%
|
-
|
|
Feb 20
2025
|
Benjamin Landry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
111,038
+21.68%
|
-
|
|
Feb 20
2025
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
192,950
+22.22%
|
-
|
|
Feb 20
2025
|
Kevin Lee Freeman Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
158,262
+15.75%
|
-
|